is there a chance BOT could become "big pharma" if they keep progressing their other programs and acquiring other opportunities if they arise? Or do we think they will get taken over before they get too big? Would be interesting to know what the end game is for the BOD. I'd say most of them are looking for that retirement nest egg, however it would be nice to have another big pharma player in Australia that hopefully pays some dividends one day.
is there a chance BOT could become "big pharma" if they keep...
-
- There are more pages in this discussion • 3,245 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.050(14.3%) |
Mkt cap ! $724.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 40.0¢ | 35.5¢ | $6.075M | 15.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 287187 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 1920397 | 33 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |